High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level

Resistance to doxorubicin (DOX) remains a big challenge to breast cancer treatment especially for triple negative breast cancer (TNBC). Our previous study revealed that the antioxidant system plays an important role in conferring metastasis derived DOX resistance. In this study, we used two-dimensio...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Man, Fu, Afu, Wu, Renfei, Wei, Na, Song, Kai, Lim, Sierin, Luo, Kathy Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771852/
https://www.ncbi.nlm.nih.gov/pubmed/35173543
http://dx.doi.org/10.7150/ijbs.65555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771852/
https://www.ncbi.nlm.nih.gov/pubmed/35173543
http://dx.doi.org/10.7150/ijbs.65555

Ejemplares similares